anne burrell glp 1 Chef and Type Diabetes Advocacy New NYPD Photos from Scene

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Infused with Mulberry Leaf Extract and sweetened with Monk Fruit.

The first randomised controlled trial of semaglutide for alcohol use disorder, published in JAMA Psychiatry in 2025, found that people taking low doses had fewer heavy drinking days, fewer cravings, and reduced alcohol intake compared to placebo

New legal actions are directed at organizations involved in illegal activities, including violating laws prohibiting the corporate practice of medicine,...

The numbers are clear: 160 million adults in the US want to improve their health and well-being through weight loss

Results Exenatide reduced fat mass and enhanced the lipolytic and oxidative capacity of WAT in diet-induced obese C57BL/6J mice